Skip to main content
Premium Trial:

Request an Annual Quote

Guardant Health, Bristol-Myers Squibb to Deploy Liquid Biopsies in Clinical Trials

NEW YORK (GenomeWeb) – Guardant Health said today that it is working with Bristol-Myers Squibb to develop the GuardantOMNI assay, a 500-plus-gene liquid biopsy panel designed to accelerate clinical trials and targeted cancer therapy research.

Redwood City, California-based Guardant has struck similar partnerships with AstraZeneca, Merck, Merck KGaA, and Pfizer.

GuardantOMNI is designed to help investigators screen patients for multiple clinical trial options using a simple blood draw to enable real-time monitoring of tumor response and tumor evolution, and to support analysis of tumor mutational burden for use with immunotherapy trials, Guardant said.

"Our agreement with Guardant Health will allow us to further explore genomic biomarkers as we advance our clinical-stage pipeline," Bruce Car, head of translational sciences at Bristol-Myers Squibb, said in a statement. "Non-invasive methods of acquiring tumor DNA will provide more data, potentially leading to greater insights into patient response."

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.